HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

alpha-Tocopherol transfer protein gene: exon skipping of all transcripts causes ataxia.

Abstract
This report concerns the characterization of the alpha-tocopherol transfer protein (alpha-TTP) gene in a Japanese family affected by ataxia with isolated vitamin E deficiency (AVED). The sequence analysis revealed a G-to-A transition at the 3' end of exon 3 in both alleles, which predicts outsplicing of this exon from premessenger RNA and the concomitant frame shift in the ataxic patient. We used reverse transcriptase-polymerase chain reaction to analyze alpha-TTP gene transcripts. All transcripts in peripheral blood lymphocytes of the AVED patient, who was treated with large doses of vitamin E, lacked exon 3. The deduced truncated protein shares only 43% of the normal alpha-TTP. Normal control tissues and cells contained normal transcripts and, unexpectedly, also the same mutant transcripts as those of the patient, although with different transcription levels. Treatment of normal fibroblasts with clinically relevant concentrations of vitamin E increased production of transcripts in a dose-dependent manner. We propose that exon skipping of all transcripts through the complete inactivation of the splice site accounts for the clinical onset of AVED and for the clinical resistance to vitamin E in our patient.
AuthorsY Tamaru, M Hirano, H Kusaka, H Ito, T Imai, S Ueno
JournalNeurology (Neurology) Vol. 49 Issue 2 Pg. 584-8 (Aug 1997) ISSN: 0028-3878 [Print] United States
PMID9270601 (Publication Type: Case Reports, Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Carrier Proteins
  • alpha-tocopherol transfer protein
  • Vitamin E
Topics
  • Adult
  • Ataxia (genetics, pathology)
  • Carrier Proteins (genetics)
  • Cells, Cultured
  • Exons
  • Female
  • Fibroblasts (metabolism)
  • Humans
  • Mutation
  • Transcription, Genetic
  • Vitamin E (pharmacology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: